Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Toya

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2022
[A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)]Atsushi Wada, Noriko Doki, Yuki Otsuka, et al.
Bone Marrow Transplantation|September 4, 2021
Impact of HLA disparity on the risk of overall mortality in patients with grade II-IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell TransplantationShigeo Fuji, Akitoshi Hakoda, Junya Kanda, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 13, 2019
The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomyShuhei Kurosawa, Noritaka Sekiya, Noriko Doki, et al.
Annals of Hematology|May 27, 2020
Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantationShuhei Kurosawa, Noriko Doki, Yasushi Senoo, et al.
Frontiers in Immunology|February 13, 2025
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experienceYusuke Uchibori, Shuhei Kurosawa, Yuho Najima, et al.
Blood Advances|September 29, 2020
Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantationKota Yoshifuji, Kyoko Inamoto, Yuko Kiridoshi, et al.
Haematologica|July 7, 2018
Prognostic factors of Erdheim-Chester disease: a nationwide survey in JapanTakashi Toya, Mizuki Ogura, Kazuhiro Toyama, et al.
Annals of Hematology|June 12, 2020
Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantationSatoshi Kaito, Atsushi Wada, Hiroto Adachi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 6, 2023
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant]Yuka Morita, Yu Yagi, Yusuke Kanemasa, et al.
Asia-Pacific Journal of Clinical Oncology|March 15, 2022
Cyclophosphamide-induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or lessAtsushi Marumo, Ikuko Omori, Shuhei Tara, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2022
[A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)]Atsushi Wada, Noriko Doki, Yuki Otsuka, et al.
Bone Marrow Transplantation|September 4, 2021
Impact of HLA disparity on the risk of overall mortality in patients with grade II-IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell TransplantationShigeo Fuji, Akitoshi Hakoda, Junya Kanda, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 13, 2019
The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomyShuhei Kurosawa, Noritaka Sekiya, Noriko Doki, et al.
Annals of Hematology|May 27, 2020
Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantationShuhei Kurosawa, Noriko Doki, Yasushi Senoo, et al.
Frontiers in Immunology|February 13, 2025
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experienceYusuke Uchibori, Shuhei Kurosawa, Yuho Najima, et al.
Blood Advances|September 29, 2020
Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantationKota Yoshifuji, Kyoko Inamoto, Yuko Kiridoshi, et al.
Haematologica|July 7, 2018
Prognostic factors of Erdheim-Chester disease: a nationwide survey in JapanTakashi Toya, Mizuki Ogura, Kazuhiro Toyama, et al.
Annals of Hematology|June 12, 2020
Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantationSatoshi Kaito, Atsushi Wada, Hiroto Adachi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 6, 2023
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant]Yuka Morita, Yu Yagi, Yusuke Kanemasa, et al.
Asia-Pacific Journal of Clinical Oncology|March 15, 2022
Cyclophosphamide-induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or lessAtsushi Marumo, Ikuko Omori, Shuhei Tara, et al.
Pageof 12